1. Home
  2. ABCB vs ORKA Comparison

ABCB vs ORKA Comparison

Compare ABCB & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ameris Bancorp

ABCB

Ameris Bancorp

SELL

Current Price

$80.13

Market Cap

5.1B

Sector

Finance

ML Signal

SELL

Logo Oruka Therapeutics Inc.

ORKA

Oruka Therapeutics Inc.

N/A

Current Price

$79.82

Market Cap

5.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ABCB
ORKA
Founded
1971
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.6B
IPO Year
2010
1997

Fundamental Metrics

Financial Performance
Metric
ABCB
ORKA
Price
$80.13
$79.82
Analyst Decision
Buy
Strong Buy
Analyst Count
7
13
Target Price
$94.17
★ $155.00
AVG Volume (30 Days)
409.3K
★ 865.0K
Earning Date
10-22-2026
11-11-2026
Dividend Yield
★ 0.99%
N/A
EPS Growth
★ 15.61
N/A
EPS
★ 2.40
N/A
Revenue
N/A
N/A
Revenue This Year
$6.52
N/A
Revenue Next Year
$4.94
N/A
P/E Ratio
$33.55
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$68.80
$20.25
52 Week High
$93.22
$115.52

Technical Indicators

Market Signals
Indicator
ABCB
ORKA
Relative Strength Index (RSI) 32.99 32.05
Support Level $73.43 $54.31
Resistance Level $83.83 $97.45
Average True Range (ATR) 1.47 4.42
MACD -0.15 -0.87
Stochastic Oscillator 27.80 9.95

Price Performance

Historical Comparison
ABCB
ORKA

About ABCB Ameris Bancorp

Ameris Bancorp is a bank holding company that operates through Ameris Bank, its subsidiary. The company operates branches in Georgia, Alabama, Florida, and South Carolina. It offers traditional banking services such as business banking, personal banking, checking, savings, mobile banking, and others. The bank is organized into four segments: the Banking Division, the Retail Mortgage Division, the Warehouse Lending Division and the Premium Finance Division. The company generates majority of its revenue from the banking division. The company intends to acquire banks in its geographic region to increase its market share and expand beyond its current market.

About ORKA Oruka Therapeutics Inc.

Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its programs are to treat and potentially modify disease by targeting mechanisms with efficacy and safety involved in disease pathology and the activity of pathogenic tissue-resident memory T cells (TRMs). Its program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. Its co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, hidradenitis suppurativa (HS), psoriatic arthritis (PsA), and other conditions.

Share on Social Networks: